|
Market Closed -
London S.E.
11:35:12 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 0.1800 GBX | 0.00% |
|
0.00% | -10.00% |
| 10-02 | Tooru gluten-free brand secures news listing | AN |
| 09-28 | Theracryf Plc, 2026 Earnings Call, Sep 28, 2026 |
Company Valuation: Theracryf Plc
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 28.21 | 12.65 | 12.58 | 3.919 | 6.191 | 6.499 | - | - |
| Change | - | -55.17% | -0.51% | -68.86% | 57.98% | 4.98% | - | - |
| Enterprise Value (EV) 1 | 11.85 | 1.317 | 6.354 | 1.358 | 3.34 | 4.91 | 6.43 | 9.519 |
| Change | - | -88.89% | 382.62% | -78.63% | 145.93% | 47.01% | 48.18% | 48.04% |
| P/E | -4x | -3.7x | -2.51x | -0.76x | -0.6x | -1.21x | -2x | -2.24x |
| PBR | 1.69x | 1.09x | 1.89x | 0.96x | 0.19x | 1.5x | - | - |
| PEG | - | 0.1x | -0.1x | 0x | 0x | 0x | 0x | 0.2x |
| Capitalization / Revenue | 103x | - | 22.9x | 7.75x | - | - | - | - |
| EV / Revenue | 43.3x | - | 11.6x | 2.68x | - | - | - | - |
| EV / EBITDA | -2.63x | -0.33x | -1.01x | -0.3x | -1.3x | -1.08x | - | - |
| EV / EBIT | -2.61x | -0.33x | -1x | -0.3x | -1.16x | -1x | -1.79x | -2.64x |
| EV / FCF | -2.88x | -0.34x | -1.24x | -0.35x | -1.04x | -1.4x | - | - |
| FCF Yield | -34.8% | -297% | -80.9% | -282% | -95.8% | -71.6% | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.0257 | -0.0124 | -0.0182 | -0.0146 | -0.00488 | -0.00212 | -0.00119 | -0.00106 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.2738 | - | 0.5487 | 0.5059 | - | - | - | - |
| EBITDA 1 | -4.508 | -3.996 | -6.32 | -4.54 | -2.574 | -4.535 | - | - |
| EBIT 1 | -4.534 | -4.016 | -6.336 | -4.555 | -2.878 | -4.892 | -3.6 | -3.6 |
| Net income 1 | -3.773 | -3.433 | -5.019 | -4.007 | -2.63 | -4.675 | -2.955 | -2.955 |
| Net Debt 1 | -16.36 | -11.33 | -6.229 | -2.561 | -2.851 | -0.6236 | -0.0689 | 3.02 |
| Reference price 2 | 0.102634 | 0.046008 | 0.045774 | 0.011061 | 0.002907 | 0.002379 | 0.002379 | 0.002379 |
| Nbr of stocks (in thousands) | 274,888 | 274,888 | 274,888 | 354,288 | 2,129,622 | 2,732,297 | - | - |
| Announcement Date | 6/15/21 | 6/8/22 | 6/7/23 | 5/28/24 | 6/3/25 | 9/28/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.19x | - | -0.88x | - | 6.5M | |
| 21.73x | 7.76x | 15.59x | 1.37% | 74.68B | |
| 30.5x | 8.78x | 27.34x | 0.04% | 58.7B | |
| 33.66x | 6.05x | 18.11x | 0.96% | 48.36B | |
| -20.81x | 215.3x | -22.29x | -.--% | 43.05B | |
| 33.24x | 3.23x | 13.97x | -.--% | 42.48B | |
| 48.26x | 5.5x | 30.21x | -.--% | 41.39B | |
| 27.77x | 7.89x | 20.51x | 0.41% | 31.29B | |
| -14.93x | 5.54x | -6.96x | -.--% | 23.93B | |
| -61.76x | 11.97x | -60.92x | -.--% | 22.22B | |
| Average | 9.65x | 30.22x | 3.47x | 0.31% | 38.61B | |
| Weighted average by Cap. | 17.34x | 30.22x | 9.46x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EVG Stock
- Valuation Theracryf Plc
Select your edition
All financial news and data tailored to specific country editions
